Quest Laborato.

45
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0TNW01017
  • NSEID: QUESTLAB
  • BSEID:
INR
100.00
0.00 (0.00%)
BSENSE

Dec 29

BSE+NSE Vol: 18000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 25.92% vs 33.94% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 2.69% vs 97.32% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.21% vs 34.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 34.40% vs 100.08% in Mar 2024

Compare Profit and Loss Results of Quest Laborato.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
103.00
112.00
-9.00
-8.04%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
103.00
112.00
-9.00
-8.04%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
-1.00
-3.00
-300.00%
Raw Materials Consumed
83.00
71.00
12.00
16.90%
Power & Fuel Cost
0.00
2.00
-2.00
-100.00%
Employee Cost
4.00
14.00
-10.00
-71.43%
Operating Expenses
0.00
3.00
-3.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
8.00
-8.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
5.00
-3.00
-60.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
87.00
107.00
-20.00
-18.69%
Operating Profit (PBDIT) excl Other Income
15.00
5.00
10.00
200.00%
Other Income
4.00
23.00
-19.00
-82.61%
Operating Profit (PBDIT)
20.00
28.00
-8.00
-28.57%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
19.00
28.00
-9.00
-32.14%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
18.00
25.00
-7.00
-28.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
18.00
25.00
-7.00
-28.00%
Provision for Tax
5.00
6.00
-1.00
-16.67%
Profit After Tax
13.00
19.00
-6.00
-31.58%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
14.00
85.00
-71.00
-83.53%
Profit Available for appropriations
27.00
105.00
-78.00
-74.29%
Appropriations
27.00
105.00
-78.00
-74.29%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
8.28
9.42
-1.14
-12.10%
Profit And Loss - Net Sales
Net Sales 103.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.92% vs 33.94% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.69% vs 97.32% in Mar 2024

Profit And Loss - Interest
Interest 0.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.21% vs 34.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 13.57 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 34.40% vs 100.08% in Mar 2024